Cyclooxygenase-Inhibiting Platinum(IV) Prodrugs with Potent Anticancer Activity
Platinum(IV) prodrugs of the [Pt(P<sub>L</sub>)(A<sub>L</sub>)(COXi)(OH)]<sup>2+</sup> type scaffold (where P<sub>L</sub> is 1,10-phenanthroline or 5,6-dimethyl-1,10-phenanthroline, A<sub>L</sub> is 1<i>S</i>,2<i>S</i&g...
Saved in:
Main Authors: | Aleen Khoury (Author), Jennette A. Sakoff (Author), Jayne Gilbert (Author), Kieran F. Scott (Author), Shawan Karan (Author), Christopher P. Gordon (Author), Janice R. Aldrich-Wright (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Potent Platinum(IV) Prodrugs That Incorporate a Biotin Moiety to Selectively Target Cancer Cells
by: Aleen Khoury, et al.
Published: (2022) -
Antibody-platinum (IV) prodrugs conjugates for targeted treatment of cutaneous squamous cell carcinoma
by: Xiangye Yin, et al.
Published: (2024) -
Layer-by-layer nanoparticles co-loading gemcitabine and platinum (IV) prodrugs for synergistic combination therapy of lung cancer
by: Zhang R, et al.
Published: (2017) -
Prodrug Approach: NSAID Conjugates of Platinum Compounds as Anti-Cancer Agents
by: NIJA B
Published: (2023) -
Monofunctional Platinum(II) Anticancer Agents
by: Suxing Jin, et al.
Published: (2021)